Global PTCA Coronary Drug Eluting Balloons Supply, Demand and Key Producers, 2026-2032
The global PTCA Coronary Drug Eluting Balloons market size is expected to reach $ 1759 million by 2032, rising at a market growth of 13.2% CAGR during the forecast period (2026-2032).
PTCA coronary drug-eluting balloons?commonly referred to as coronary drug-coated/drug-eluting balloons (coronary DCB/DEB)?are angioplasty balloons used in percutaneous transluminal coronary angioplasty (PTCA) with an antiproliferative drug (predominantly paclitaxel, with growing ?limus? exploration) plus an excipient/carrier layer on the balloon surface. During inflation, they provide immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic proposition is ?leave nothing behind,? aiming to avoid additional permanent metal/polymer layers and preserve future treatment flexibility?most compelling in coronary in-stent restenosis (ISR), small-vessel disease, and selected bifurcation strategies. In 2025, global PTCA coronary drug-eluting balloons production reached approximately 755 k units and price is 940 USD/Unit.The average gross profit margin of this product is 73%.
A clear commercialization inflection has emerged: in March 2024, the U.S. FDA approved the first coronary drug-coated balloon for ISR (the AGENT DCB), significantly increasing global visibility and strengthening hospital adoption confidence. Concurrent randomized evidence and high-impact editorial perspectives reinforced the evidence base for ISR, accelerating the shift from experience-driven use to pathway-manageable standard practice. Over a longer horizon, coronary intervention is evolving from implant-centric approaches toward repair strategies that prioritize controllable reintervention, where DCBs benefit from a value narrative centered on reducing multilayer implants and long-term implant burden.
The key constraints are indication boundaries and reproducibility. Beyond ISR?where evidence is strongest?recent data in previously untreated, non-complex coronary disease did not support DCB as a straightforward substitute for second-generation DES as the preferred strategy, underscoring the need for tighter lesion selection, procedural standardization, and follow-up evidence as the market expands. Coronary anatomy also imposes higher demands on deliverability, coating integrity, and drug-transfer performance; batch variability can translate into outsized clinical experience and access risk. Combined with regional differences in combination-product regulation and hospital value assessment, manufacturers must build durable, repeatable capabilities across evidence, quality systems, and supply assurance.
Demand is shifting from single devices toward repeatable coronary repair solutions. Clinical practice increasingly emphasizes lesion preparation (adequate pre-dilation, managing calcium and dissection risk), intraprocedural assessment, and avoiding additional stent layers?clarifying DCB?s role in ISR, small vessels, and selected bifurcation strategies, often in combination with specialty balloons, plaque modification, and imaging guidance. With the U.S. entering a compliant ?coronary DCB era,? ecosystem build-out around indication education, technique standardization, and real-world follow-up is accelerating, enabling hospitals to incorporate DCB into managed pathways and bundled device sets with greater predictability and scaling potential.
Upstream differentiation is ultimately a platform capability spanning materials, coating, and validation. Key inputs include balloon films and catheter polymers (multi-durometer shafts, liners, reinforcement braids/coils), drug APIs (paclitaxel or limus agents) with crystallinity/particle control, excipient and solvent systems, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Because coronary use is highly sensitive to particulate control, coating integrity, dose consistency, deliverability, and stability, the supply chain must operate with medical-grade traceability, clean manufacturing, robust change control, and strict release standards to industrialize ?drug transfer + delivery performance + long-term stability? as a repeatable engineering capability.
This report studies the global PTCA Coronary Drug Eluting Balloons production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PTCA Coronary Drug Eluting Balloons and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of PTCA Coronary Drug Eluting Balloons that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PTCA Coronary Drug Eluting Balloons total production and demand, 2021-2032, (K Units)
Global PTCA Coronary Drug Eluting Balloons total production value, 2021-2032, (USD Million)
Global PTCA Coronary Drug Eluting Balloons production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global PTCA Coronary Drug Eluting Balloons consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: PTCA Coronary Drug Eluting Balloons domestic production, consumption, key domestic manufacturers and share
Global PTCA Coronary Drug Eluting Balloons production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global PTCA Coronary Drug Eluting Balloons production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global PTCA Coronary Drug Eluting Balloons production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global PTCA Coronary Drug Eluting Balloons market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Eurocor, Teleflex, Yinyi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PTCA Coronary Drug Eluting Balloons market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global PTCA Coronary Drug Eluting Balloons Market, By Region:
1. How big is the global PTCA Coronary Drug Eluting Balloons market?
2. What is the demand of the global PTCA Coronary Drug Eluting Balloons market?
3. What is the year over year growth of the global PTCA Coronary Drug Eluting Balloons market?
4. What is the production and production value of the global PTCA Coronary Drug Eluting Balloons market?
5. Who are the key producers in the global PTCA Coronary Drug Eluting Balloons market?
6. What are the growth factors driving the market demand?
PTCA coronary drug-eluting balloons?commonly referred to as coronary drug-coated/drug-eluting balloons (coronary DCB/DEB)?are angioplasty balloons used in percutaneous transluminal coronary angioplasty (PTCA) with an antiproliferative drug (predominantly paclitaxel, with growing ?limus? exploration) plus an excipient/carrier layer on the balloon surface. During inflation, they provide immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic proposition is ?leave nothing behind,? aiming to avoid additional permanent metal/polymer layers and preserve future treatment flexibility?most compelling in coronary in-stent restenosis (ISR), small-vessel disease, and selected bifurcation strategies. In 2025, global PTCA coronary drug-eluting balloons production reached approximately 755 k units and price is 940 USD/Unit.The average gross profit margin of this product is 73%.
A clear commercialization inflection has emerged: in March 2024, the U.S. FDA approved the first coronary drug-coated balloon for ISR (the AGENT DCB), significantly increasing global visibility and strengthening hospital adoption confidence. Concurrent randomized evidence and high-impact editorial perspectives reinforced the evidence base for ISR, accelerating the shift from experience-driven use to pathway-manageable standard practice. Over a longer horizon, coronary intervention is evolving from implant-centric approaches toward repair strategies that prioritize controllable reintervention, where DCBs benefit from a value narrative centered on reducing multilayer implants and long-term implant burden.
The key constraints are indication boundaries and reproducibility. Beyond ISR?where evidence is strongest?recent data in previously untreated, non-complex coronary disease did not support DCB as a straightforward substitute for second-generation DES as the preferred strategy, underscoring the need for tighter lesion selection, procedural standardization, and follow-up evidence as the market expands. Coronary anatomy also imposes higher demands on deliverability, coating integrity, and drug-transfer performance; batch variability can translate into outsized clinical experience and access risk. Combined with regional differences in combination-product regulation and hospital value assessment, manufacturers must build durable, repeatable capabilities across evidence, quality systems, and supply assurance.
Demand is shifting from single devices toward repeatable coronary repair solutions. Clinical practice increasingly emphasizes lesion preparation (adequate pre-dilation, managing calcium and dissection risk), intraprocedural assessment, and avoiding additional stent layers?clarifying DCB?s role in ISR, small vessels, and selected bifurcation strategies, often in combination with specialty balloons, plaque modification, and imaging guidance. With the U.S. entering a compliant ?coronary DCB era,? ecosystem build-out around indication education, technique standardization, and real-world follow-up is accelerating, enabling hospitals to incorporate DCB into managed pathways and bundled device sets with greater predictability and scaling potential.
Upstream differentiation is ultimately a platform capability spanning materials, coating, and validation. Key inputs include balloon films and catheter polymers (multi-durometer shafts, liners, reinforcement braids/coils), drug APIs (paclitaxel or limus agents) with crystallinity/particle control, excipient and solvent systems, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Because coronary use is highly sensitive to particulate control, coating integrity, dose consistency, deliverability, and stability, the supply chain must operate with medical-grade traceability, clean manufacturing, robust change control, and strict release standards to industrialize ?drug transfer + delivery performance + long-term stability? as a repeatable engineering capability.
This report studies the global PTCA Coronary Drug Eluting Balloons production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PTCA Coronary Drug Eluting Balloons and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of PTCA Coronary Drug Eluting Balloons that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PTCA Coronary Drug Eluting Balloons total production and demand, 2021-2032, (K Units)
Global PTCA Coronary Drug Eluting Balloons total production value, 2021-2032, (USD Million)
Global PTCA Coronary Drug Eluting Balloons production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global PTCA Coronary Drug Eluting Balloons consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: PTCA Coronary Drug Eluting Balloons domestic production, consumption, key domestic manufacturers and share
Global PTCA Coronary Drug Eluting Balloons production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global PTCA Coronary Drug Eluting Balloons production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global PTCA Coronary Drug Eluting Balloons production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global PTCA Coronary Drug Eluting Balloons market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Eurocor, Teleflex, Yinyi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PTCA Coronary Drug Eluting Balloons market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global PTCA Coronary Drug Eluting Balloons Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Paclitaxel-based
- limus
- Other
- In-Stent Restenosi
- De novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Cardiac Catheterization Lab
- Hospital
- Other
- B. Braun
- Eurocor
- Teleflex
- Yinyi
1. How big is the global PTCA Coronary Drug Eluting Balloons market?
2. What is the demand of the global PTCA Coronary Drug Eluting Balloons market?
3. What is the year over year growth of the global PTCA Coronary Drug Eluting Balloons market?
4. What is the production and production value of the global PTCA Coronary Drug Eluting Balloons market?
5. Who are the key producers in the global PTCA Coronary Drug Eluting Balloons market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PTCA Coronary Drug Eluting Balloons Introduction
1.2 World PTCA Coronary Drug Eluting Balloons Supply & Forecast
1.2.1 World PTCA Coronary Drug Eluting Balloons Production Value (2021 & 2025 & 2032)
1.2.2 World PTCA Coronary Drug Eluting Balloons Production (2021-2032)
1.2.3 World PTCA Coronary Drug Eluting Balloons Pricing Trends (2021-2032)
1.3 World PTCA Coronary Drug Eluting Balloons Production by Region (Based on Production Site)
1.3.1 World PTCA Coronary Drug Eluting Balloons Production Value by Region (2021-2032)
1.3.2 World PTCA Coronary Drug Eluting Balloons Production by Region (2021-2032)
1.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Region (2021-2032)
1.3.4 North America PTCA Coronary Drug Eluting Balloons Production (2021-2032)
1.3.5 Europe PTCA Coronary Drug Eluting Balloons Production (2021-2032)
1.3.6 China PTCA Coronary Drug Eluting Balloons Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 PTCA Coronary Drug Eluting Balloons Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PTCA Coronary Drug Eluting Balloons Major Market Trends
2 DEMAND SUMMARY
2.1 World PTCA Coronary Drug Eluting Balloons Demand (2021-2032)
2.2 World PTCA Coronary Drug Eluting Balloons Consumption by Region
2.2.1 World PTCA Coronary Drug Eluting Balloons Consumption by Region (2021-2026)
2.2.2 World PTCA Coronary Drug Eluting Balloons Consumption Forecast by Region (2027-2032)
2.3 United States PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.4 China PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.5 Europe PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.6 Japan PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.7 South Korea PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.8 ASEAN PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.9 India PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PTCA Coronary Drug Eluting Balloons Production Value by Manufacturer (2021-2026)
3.2 World PTCA Coronary Drug Eluting Balloons Production by Manufacturer (2021-2026)
3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Manufacturer (2021-2026)
3.4 PTCA Coronary Drug Eluting Balloons Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PTCA Coronary Drug Eluting Balloons Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PTCA Coronary Drug Eluting Balloons in 2025
3.5.3 Global Concentration Ratios (CR8) for PTCA Coronary Drug Eluting Balloons in 2025
3.6 PTCA Coronary Drug Eluting Balloons Market: Overall Company Footprint Analysis
3.6.1 PTCA Coronary Drug Eluting Balloons Market: Region Footprint
3.6.2 PTCA Coronary Drug Eluting Balloons Market: Company Product Type Footprint
3.6.3 PTCA Coronary Drug Eluting Balloons Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PTCA Coronary Drug Eluting Balloons Production Value Comparison
4.1.1 United States VS China: PTCA Coronary Drug Eluting Balloons Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: PTCA Coronary Drug Eluting Balloons Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: PTCA Coronary Drug Eluting Balloons Production Comparison
4.2.1 United States VS China: PTCA Coronary Drug Eluting Balloons Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: PTCA Coronary Drug Eluting Balloons Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: PTCA Coronary Drug Eluting Balloons Consumption Comparison
4.3.1 United States VS China: PTCA Coronary Drug Eluting Balloons Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: PTCA Coronary Drug Eluting Balloons Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based PTCA Coronary Drug Eluting Balloons Manufacturers and Market Share, 2021-2026
4.4.1 United States Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value (2021-2026)
4.4.3 United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production (2021-2026)
4.5 China Based PTCA Coronary Drug Eluting Balloons Manufacturers and Market Share
4.5.1 China Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value (2021-2026)
4.5.3 China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production (2021-2026)
4.6 Rest of World Based PTCA Coronary Drug Eluting Balloons Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World PTCA Coronary Drug Eluting Balloons Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Paclitaxel-based
5.2.2 limus
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World PTCA Coronary Drug Eluting Balloons Production by Type (2021-2032)
5.3.2 World PTCA Coronary Drug Eluting Balloons Production Value by Type (2021-2032)
5.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY USE SCENARIO
6.1 World PTCA Coronary Drug Eluting Balloons Market Size Overview by Use Scenario: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Use Scenario
6.2.1 In-Stent Restenosi
6.2.2 De novo
6.2.3 Small Vessel
6.3 Market Segment by Use Scenario
6.3.1 World PTCA Coronary Drug Eluting Balloons Production by Use Scenario (2021-2032)
6.3.2 World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario (2021-2032)
6.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Use Scenario (2021-2032)
7 MARKET ANALYSIS BY BALLOON PLATFORM MECHANICS
7.1 World PTCA Coronary Drug Eluting Balloons Market Size Overview by Balloon Platform Mechanics: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Balloon Platform Mechanics
7.2.1 Semi-/Compliant
7.2.2 Non-compliant
7.2.3 Other
7.3 Market Segment by Balloon Platform Mechanics
7.3.1 World PTCA Coronary Drug Eluting Balloons Production by Balloon Platform Mechanics (2021-2032)
7.3.2 World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics (2021-2032)
7.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Balloon Platform Mechanics (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World PTCA Coronary Drug Eluting Balloons Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cardiac Catheterization Lab
8.2.2 Hospital
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World PTCA Coronary Drug Eluting Balloons Production by Application (2021-2032)
8.3.2 World PTCA Coronary Drug Eluting Balloons Production Value by Application (2021-2032)
8.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 B. Braun
9.1.1 B. Braun Details
9.1.2 B. Braun Major Business
9.1.3 B. Braun PTCA Coronary Drug Eluting Balloons Product and Services
9.1.4 B. Braun PTCA Coronary Drug Eluting Balloons Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 B. Braun Recent Developments/Updates
9.1.6 B. Braun Competitive Strengths & Weaknesses
9.2 Eurocor
9.2.1 Eurocor Details
9.2.2 Eurocor Major Business
9.2.3 Eurocor PTCA Coronary Drug Eluting Balloons Product and Services
9.2.4 Eurocor PTCA Coronary Drug Eluting Balloons Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Eurocor Recent Developments/Updates
9.2.6 Eurocor Competitive Strengths & Weaknesses
9.3 Teleflex
9.3.1 Teleflex Details
9.3.2 Teleflex Major Business
9.3.3 Teleflex PTCA Coronary Drug Eluting Balloons Product and Services
9.3.4 Teleflex PTCA Coronary Drug Eluting Balloons Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Teleflex Recent Developments/Updates
9.3.6 Teleflex Competitive Strengths & Weaknesses
9.4 Yinyi
9.4.1 Yinyi Details
9.4.2 Yinyi Major Business
9.4.3 Yinyi PTCA Coronary Drug Eluting Balloons Product and Services
9.4.4 Yinyi PTCA Coronary Drug Eluting Balloons Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Yinyi Recent Developments/Updates
9.4.6 Yinyi Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 PTCA Coronary Drug Eluting Balloons Industry Chain
10.2 PTCA Coronary Drug Eluting Balloons Upstream Analysis
10.2.1 PTCA Coronary Drug Eluting Balloons Core Raw Materials
10.2.2 Main Manufacturers of PTCA Coronary Drug Eluting Balloons Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 PTCA Coronary Drug Eluting Balloons Production Mode
10.6 PTCA Coronary Drug Eluting Balloons Procurement Model
10.7 PTCA Coronary Drug Eluting Balloons Industry Sales Model and Sales Channels
10.7.1 PTCA Coronary Drug Eluting Balloons Sales Model
10.7.2 PTCA Coronary Drug Eluting Balloons Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 PTCA Coronary Drug Eluting Balloons Introduction
1.2 World PTCA Coronary Drug Eluting Balloons Supply & Forecast
1.2.1 World PTCA Coronary Drug Eluting Balloons Production Value (2021 & 2025 & 2032)
1.2.2 World PTCA Coronary Drug Eluting Balloons Production (2021-2032)
1.2.3 World PTCA Coronary Drug Eluting Balloons Pricing Trends (2021-2032)
1.3 World PTCA Coronary Drug Eluting Balloons Production by Region (Based on Production Site)
1.3.1 World PTCA Coronary Drug Eluting Balloons Production Value by Region (2021-2032)
1.3.2 World PTCA Coronary Drug Eluting Balloons Production by Region (2021-2032)
1.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Region (2021-2032)
1.3.4 North America PTCA Coronary Drug Eluting Balloons Production (2021-2032)
1.3.5 Europe PTCA Coronary Drug Eluting Balloons Production (2021-2032)
1.3.6 China PTCA Coronary Drug Eluting Balloons Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 PTCA Coronary Drug Eluting Balloons Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PTCA Coronary Drug Eluting Balloons Major Market Trends
2 DEMAND SUMMARY
2.1 World PTCA Coronary Drug Eluting Balloons Demand (2021-2032)
2.2 World PTCA Coronary Drug Eluting Balloons Consumption by Region
2.2.1 World PTCA Coronary Drug Eluting Balloons Consumption by Region (2021-2026)
2.2.2 World PTCA Coronary Drug Eluting Balloons Consumption Forecast by Region (2027-2032)
2.3 United States PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.4 China PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.5 Europe PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.6 Japan PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.7 South Korea PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.8 ASEAN PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
2.9 India PTCA Coronary Drug Eluting Balloons Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PTCA Coronary Drug Eluting Balloons Production Value by Manufacturer (2021-2026)
3.2 World PTCA Coronary Drug Eluting Balloons Production by Manufacturer (2021-2026)
3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Manufacturer (2021-2026)
3.4 PTCA Coronary Drug Eluting Balloons Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PTCA Coronary Drug Eluting Balloons Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PTCA Coronary Drug Eluting Balloons in 2025
3.5.3 Global Concentration Ratios (CR8) for PTCA Coronary Drug Eluting Balloons in 2025
3.6 PTCA Coronary Drug Eluting Balloons Market: Overall Company Footprint Analysis
3.6.1 PTCA Coronary Drug Eluting Balloons Market: Region Footprint
3.6.2 PTCA Coronary Drug Eluting Balloons Market: Company Product Type Footprint
3.6.3 PTCA Coronary Drug Eluting Balloons Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PTCA Coronary Drug Eluting Balloons Production Value Comparison
4.1.1 United States VS China: PTCA Coronary Drug Eluting Balloons Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: PTCA Coronary Drug Eluting Balloons Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: PTCA Coronary Drug Eluting Balloons Production Comparison
4.2.1 United States VS China: PTCA Coronary Drug Eluting Balloons Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: PTCA Coronary Drug Eluting Balloons Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: PTCA Coronary Drug Eluting Balloons Consumption Comparison
4.3.1 United States VS China: PTCA Coronary Drug Eluting Balloons Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: PTCA Coronary Drug Eluting Balloons Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based PTCA Coronary Drug Eluting Balloons Manufacturers and Market Share, 2021-2026
4.4.1 United States Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value (2021-2026)
4.4.3 United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production (2021-2026)
4.5 China Based PTCA Coronary Drug Eluting Balloons Manufacturers and Market Share
4.5.1 China Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value (2021-2026)
4.5.3 China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production (2021-2026)
4.6 Rest of World Based PTCA Coronary Drug Eluting Balloons Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World PTCA Coronary Drug Eluting Balloons Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Paclitaxel-based
5.2.2 limus
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World PTCA Coronary Drug Eluting Balloons Production by Type (2021-2032)
5.3.2 World PTCA Coronary Drug Eluting Balloons Production Value by Type (2021-2032)
5.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY USE SCENARIO
6.1 World PTCA Coronary Drug Eluting Balloons Market Size Overview by Use Scenario: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Use Scenario
6.2.1 In-Stent Restenosi
6.2.2 De novo
6.2.3 Small Vessel
6.3 Market Segment by Use Scenario
6.3.1 World PTCA Coronary Drug Eluting Balloons Production by Use Scenario (2021-2032)
6.3.2 World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario (2021-2032)
6.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Use Scenario (2021-2032)
7 MARKET ANALYSIS BY BALLOON PLATFORM MECHANICS
7.1 World PTCA Coronary Drug Eluting Balloons Market Size Overview by Balloon Platform Mechanics: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Balloon Platform Mechanics
7.2.1 Semi-/Compliant
7.2.2 Non-compliant
7.2.3 Other
7.3 Market Segment by Balloon Platform Mechanics
7.3.1 World PTCA Coronary Drug Eluting Balloons Production by Balloon Platform Mechanics (2021-2032)
7.3.2 World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics (2021-2032)
7.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Balloon Platform Mechanics (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World PTCA Coronary Drug Eluting Balloons Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cardiac Catheterization Lab
8.2.2 Hospital
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World PTCA Coronary Drug Eluting Balloons Production by Application (2021-2032)
8.3.2 World PTCA Coronary Drug Eluting Balloons Production Value by Application (2021-2032)
8.3.3 World PTCA Coronary Drug Eluting Balloons Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 B. Braun
9.1.1 B. Braun Details
9.1.2 B. Braun Major Business
9.1.3 B. Braun PTCA Coronary Drug Eluting Balloons Product and Services
9.1.4 B. Braun PTCA Coronary Drug Eluting Balloons Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 B. Braun Recent Developments/Updates
9.1.6 B. Braun Competitive Strengths & Weaknesses
9.2 Eurocor
9.2.1 Eurocor Details
9.2.2 Eurocor Major Business
9.2.3 Eurocor PTCA Coronary Drug Eluting Balloons Product and Services
9.2.4 Eurocor PTCA Coronary Drug Eluting Balloons Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Eurocor Recent Developments/Updates
9.2.6 Eurocor Competitive Strengths & Weaknesses
9.3 Teleflex
9.3.1 Teleflex Details
9.3.2 Teleflex Major Business
9.3.3 Teleflex PTCA Coronary Drug Eluting Balloons Product and Services
9.3.4 Teleflex PTCA Coronary Drug Eluting Balloons Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Teleflex Recent Developments/Updates
9.3.6 Teleflex Competitive Strengths & Weaknesses
9.4 Yinyi
9.4.1 Yinyi Details
9.4.2 Yinyi Major Business
9.4.3 Yinyi PTCA Coronary Drug Eluting Balloons Product and Services
9.4.4 Yinyi PTCA Coronary Drug Eluting Balloons Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Yinyi Recent Developments/Updates
9.4.6 Yinyi Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 PTCA Coronary Drug Eluting Balloons Industry Chain
10.2 PTCA Coronary Drug Eluting Balloons Upstream Analysis
10.2.1 PTCA Coronary Drug Eluting Balloons Core Raw Materials
10.2.2 Main Manufacturers of PTCA Coronary Drug Eluting Balloons Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 PTCA Coronary Drug Eluting Balloons Production Mode
10.6 PTCA Coronary Drug Eluting Balloons Procurement Model
10.7 PTCA Coronary Drug Eluting Balloons Industry Sales Model and Sales Channels
10.7.1 PTCA Coronary Drug Eluting Balloons Sales Model
10.7.2 PTCA Coronary Drug Eluting Balloons Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World PTCA Coronary Drug Eluting Balloons Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World PTCA Coronary Drug Eluting Balloons Production Value by Region (2021-2026) & (USD Million)
Table 3. World PTCA Coronary Drug Eluting Balloons Production Value by Region (2027-2032) & (USD Million)
Table 4. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Region (2021-2026)
Table 5. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Region (2027-2032)
Table 6. World PTCA Coronary Drug Eluting Balloons Production by Region (2021-2026) & (K Units)
Table 7. World PTCA Coronary Drug Eluting Balloons Production by Region (2027-2032) & (K Units)
Table 8. World PTCA Coronary Drug Eluting Balloons Production Market Share by Region (2021-2026)
Table 9. World PTCA Coronary Drug Eluting Balloons Production Market Share by Region (2027-2032)
Table 10. World PTCA Coronary Drug Eluting Balloons Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World PTCA Coronary Drug Eluting Balloons Average Price by Region (2027-2032) & (US$/Unit)
Table 12. PTCA Coronary Drug Eluting Balloons Major Market Trends
Table 13. World PTCA Coronary Drug Eluting Balloons Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World PTCA Coronary Drug Eluting Balloons Consumption by Region (2021-2026) & (K Units)
Table 15. World PTCA Coronary Drug Eluting Balloons Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World PTCA Coronary Drug Eluting Balloons Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key PTCA Coronary Drug Eluting Balloons Producers in 2025
Table 18. World PTCA Coronary Drug Eluting Balloons Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key PTCA Coronary Drug Eluting Balloons Producers in 2025
Table 20. World PTCA Coronary Drug Eluting Balloons Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global PTCA Coronary Drug Eluting Balloons Company Evaluation Quadrant
Table 22. World PTCA Coronary Drug Eluting Balloons Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and PTCA Coronary Drug Eluting Balloons Production Site of Key Manufacturer
Table 24. PTCA Coronary Drug Eluting Balloons Market: Company Product Type Footprint
Table 25. PTCA Coronary Drug Eluting Balloons Market: Company Product Application Footprint
Table 26. PTCA Coronary Drug Eluting Balloons Competitive Factors
Table 27. PTCA Coronary Drug Eluting Balloons New Entrant and Capacity Expansion Plans
Table 28. PTCA Coronary Drug Eluting Balloons Mergers & Acquisitions Activity
Table 29. United States VS China PTCA Coronary Drug Eluting Balloons Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China PTCA Coronary Drug Eluting Balloons Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China PTCA Coronary Drug Eluting Balloons Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share (2021-2026)
Table 37. China Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share (2021-2026)
Table 42. Rest of World Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share (2021-2026)
Table 47. World PTCA Coronary Drug Eluting Balloons Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World PTCA Coronary Drug Eluting Balloons Production by Type (2021-2026) & (K Units)
Table 49. World PTCA Coronary Drug Eluting Balloons Production by Type (2027-2032) & (K Units)
Table 50. World PTCA Coronary Drug Eluting Balloons Production Value by Type (2021-2026) & (USD Million)
Table 51. World PTCA Coronary Drug Eluting Balloons Production Value by Type (2027-2032) & (USD Million)
Table 52. World PTCA Coronary Drug Eluting Balloons Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World PTCA Coronary Drug Eluting Balloons Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Table 55. World PTCA Coronary Drug Eluting Balloons Production by Use Scenario (2021-2026) & (K Units)
Table 56. World PTCA Coronary Drug Eluting Balloons Production by Use Scenario (2027-2032) & (K Units)
Table 57. World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario (2021-2026) & (USD Million)
Table 58. World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario (2027-2032) & (USD Million)
Table 59. World PTCA Coronary Drug Eluting Balloons Average Price by Use Scenario (2021-2026) & (US$/Unit)
Table 60. World PTCA Coronary Drug Eluting Balloons Average Price by Use Scenario (2027-2032) & (US$/Unit)
Table 61. World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Table 62. World PTCA Coronary Drug Eluting Balloons Production by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 63. World PTCA Coronary Drug Eluting Balloons Production by Balloon Platform Mechanics (2027-2032) & (K Units)
Table 64. World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics (2021-2026) & (USD Million)
Table 65. World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics (2027-2032) & (USD Million)
Table 66. World PTCA Coronary Drug Eluting Balloons Average Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 67. World PTCA Coronary Drug Eluting Balloons Average Price by Balloon Platform Mechanics (2027-2032) & (US$/Unit)
Table 68. World PTCA Coronary Drug Eluting Balloons Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World PTCA Coronary Drug Eluting Balloons Production by Application (2021-2026) & (K Units)
Table 70. World PTCA Coronary Drug Eluting Balloons Production by Application (2027-2032) & (K Units)
Table 71. World PTCA Coronary Drug Eluting Balloons Production Value by Application (2021-2026) & (USD Million)
Table 72. World PTCA Coronary Drug Eluting Balloons Production Value by Application (2027-2032) & (USD Million)
Table 73. World PTCA Coronary Drug Eluting Balloons Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World PTCA Coronary Drug Eluting Balloons Average Price by Application (2027-2032) & (US$/Unit)
Table 75. B. Braun Basic Information, Manufacturing Base and Competitors
Table 76. B. Braun Major Business
Table 77. B. Braun PTCA Coronary Drug Eluting Balloons Product and Services
Table 78. B. Braun PTCA Coronary Drug Eluting Balloons Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. B. Braun Recent Developments/Updates
Table 80. B. Braun Competitive Strengths & Weaknesses
Table 81. Eurocor Basic Information, Manufacturing Base and Competitors
Table 82. Eurocor Major Business
Table 83. Eurocor PTCA Coronary Drug Eluting Balloons Product and Services
Table 84. Eurocor PTCA Coronary Drug Eluting Balloons Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Eurocor Recent Developments/Updates
Table 86. Eurocor Competitive Strengths & Weaknesses
Table 87. Teleflex Basic Information, Manufacturing Base and Competitors
Table 88. Teleflex Major Business
Table 89. Teleflex PTCA Coronary Drug Eluting Balloons Product and Services
Table 90. Teleflex PTCA Coronary Drug Eluting Balloons Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Teleflex Recent Developments/Updates
Table 92. Teleflex Competitive Strengths & Weaknesses
Table 93. Yinyi Basic Information, Manufacturing Base and Competitors
Table 94. Yinyi Major Business
Table 95. Yinyi PTCA Coronary Drug Eluting Balloons Product and Services
Table 96. Yinyi PTCA Coronary Drug Eluting Balloons Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Yinyi Recent Developments/Updates
Table 98. Yinyi Competitive Strengths & Weaknesses
Table 99. Global Key Players of PTCA Coronary Drug Eluting Balloons Upstream (Raw Materials)
Table 100. Global PTCA Coronary Drug Eluting Balloons Typical Customers
Table 101. PTCA Coronary Drug Eluting Balloons Typical Distributors
Table 1. World PTCA Coronary Drug Eluting Balloons Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World PTCA Coronary Drug Eluting Balloons Production Value by Region (2021-2026) & (USD Million)
Table 3. World PTCA Coronary Drug Eluting Balloons Production Value by Region (2027-2032) & (USD Million)
Table 4. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Region (2021-2026)
Table 5. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Region (2027-2032)
Table 6. World PTCA Coronary Drug Eluting Balloons Production by Region (2021-2026) & (K Units)
Table 7. World PTCA Coronary Drug Eluting Balloons Production by Region (2027-2032) & (K Units)
Table 8. World PTCA Coronary Drug Eluting Balloons Production Market Share by Region (2021-2026)
Table 9. World PTCA Coronary Drug Eluting Balloons Production Market Share by Region (2027-2032)
Table 10. World PTCA Coronary Drug Eluting Balloons Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World PTCA Coronary Drug Eluting Balloons Average Price by Region (2027-2032) & (US$/Unit)
Table 12. PTCA Coronary Drug Eluting Balloons Major Market Trends
Table 13. World PTCA Coronary Drug Eluting Balloons Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World PTCA Coronary Drug Eluting Balloons Consumption by Region (2021-2026) & (K Units)
Table 15. World PTCA Coronary Drug Eluting Balloons Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World PTCA Coronary Drug Eluting Balloons Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key PTCA Coronary Drug Eluting Balloons Producers in 2025
Table 18. World PTCA Coronary Drug Eluting Balloons Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key PTCA Coronary Drug Eluting Balloons Producers in 2025
Table 20. World PTCA Coronary Drug Eluting Balloons Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global PTCA Coronary Drug Eluting Balloons Company Evaluation Quadrant
Table 22. World PTCA Coronary Drug Eluting Balloons Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and PTCA Coronary Drug Eluting Balloons Production Site of Key Manufacturer
Table 24. PTCA Coronary Drug Eluting Balloons Market: Company Product Type Footprint
Table 25. PTCA Coronary Drug Eluting Balloons Market: Company Product Application Footprint
Table 26. PTCA Coronary Drug Eluting Balloons Competitive Factors
Table 27. PTCA Coronary Drug Eluting Balloons New Entrant and Capacity Expansion Plans
Table 28. PTCA Coronary Drug Eluting Balloons Mergers & Acquisitions Activity
Table 29. United States VS China PTCA Coronary Drug Eluting Balloons Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China PTCA Coronary Drug Eluting Balloons Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China PTCA Coronary Drug Eluting Balloons Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share (2021-2026)
Table 37. China Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share (2021-2026)
Table 42. Rest of World Based PTCA Coronary Drug Eluting Balloons Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share (2021-2026)
Table 47. World PTCA Coronary Drug Eluting Balloons Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World PTCA Coronary Drug Eluting Balloons Production by Type (2021-2026) & (K Units)
Table 49. World PTCA Coronary Drug Eluting Balloons Production by Type (2027-2032) & (K Units)
Table 50. World PTCA Coronary Drug Eluting Balloons Production Value by Type (2021-2026) & (USD Million)
Table 51. World PTCA Coronary Drug Eluting Balloons Production Value by Type (2027-2032) & (USD Million)
Table 52. World PTCA Coronary Drug Eluting Balloons Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World PTCA Coronary Drug Eluting Balloons Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Table 55. World PTCA Coronary Drug Eluting Balloons Production by Use Scenario (2021-2026) & (K Units)
Table 56. World PTCA Coronary Drug Eluting Balloons Production by Use Scenario (2027-2032) & (K Units)
Table 57. World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario (2021-2026) & (USD Million)
Table 58. World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario (2027-2032) & (USD Million)
Table 59. World PTCA Coronary Drug Eluting Balloons Average Price by Use Scenario (2021-2026) & (US$/Unit)
Table 60. World PTCA Coronary Drug Eluting Balloons Average Price by Use Scenario (2027-2032) & (US$/Unit)
Table 61. World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Table 62. World PTCA Coronary Drug Eluting Balloons Production by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 63. World PTCA Coronary Drug Eluting Balloons Production by Balloon Platform Mechanics (2027-2032) & (K Units)
Table 64. World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics (2021-2026) & (USD Million)
Table 65. World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics (2027-2032) & (USD Million)
Table 66. World PTCA Coronary Drug Eluting Balloons Average Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 67. World PTCA Coronary Drug Eluting Balloons Average Price by Balloon Platform Mechanics (2027-2032) & (US$/Unit)
Table 68. World PTCA Coronary Drug Eluting Balloons Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World PTCA Coronary Drug Eluting Balloons Production by Application (2021-2026) & (K Units)
Table 70. World PTCA Coronary Drug Eluting Balloons Production by Application (2027-2032) & (K Units)
Table 71. World PTCA Coronary Drug Eluting Balloons Production Value by Application (2021-2026) & (USD Million)
Table 72. World PTCA Coronary Drug Eluting Balloons Production Value by Application (2027-2032) & (USD Million)
Table 73. World PTCA Coronary Drug Eluting Balloons Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World PTCA Coronary Drug Eluting Balloons Average Price by Application (2027-2032) & (US$/Unit)
Table 75. B. Braun Basic Information, Manufacturing Base and Competitors
Table 76. B. Braun Major Business
Table 77. B. Braun PTCA Coronary Drug Eluting Balloons Product and Services
Table 78. B. Braun PTCA Coronary Drug Eluting Balloons Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. B. Braun Recent Developments/Updates
Table 80. B. Braun Competitive Strengths & Weaknesses
Table 81. Eurocor Basic Information, Manufacturing Base and Competitors
Table 82. Eurocor Major Business
Table 83. Eurocor PTCA Coronary Drug Eluting Balloons Product and Services
Table 84. Eurocor PTCA Coronary Drug Eluting Balloons Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Eurocor Recent Developments/Updates
Table 86. Eurocor Competitive Strengths & Weaknesses
Table 87. Teleflex Basic Information, Manufacturing Base and Competitors
Table 88. Teleflex Major Business
Table 89. Teleflex PTCA Coronary Drug Eluting Balloons Product and Services
Table 90. Teleflex PTCA Coronary Drug Eluting Balloons Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Teleflex Recent Developments/Updates
Table 92. Teleflex Competitive Strengths & Weaknesses
Table 93. Yinyi Basic Information, Manufacturing Base and Competitors
Table 94. Yinyi Major Business
Table 95. Yinyi PTCA Coronary Drug Eluting Balloons Product and Services
Table 96. Yinyi PTCA Coronary Drug Eluting Balloons Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Yinyi Recent Developments/Updates
Table 98. Yinyi Competitive Strengths & Weaknesses
Table 99. Global Key Players of PTCA Coronary Drug Eluting Balloons Upstream (Raw Materials)
Table 100. Global PTCA Coronary Drug Eluting Balloons Typical Customers
Table 101. PTCA Coronary Drug Eluting Balloons Typical Distributors
LIST OF FIGURES
Figure 1. PTCA Coronary Drug Eluting Balloons Picture
Figure 2. World PTCA Coronary Drug Eluting Balloons Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World PTCA Coronary Drug Eluting Balloons Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World PTCA Coronary Drug Eluting Balloons Production (2021-2032) & (K Units)
Figure 5. World PTCA Coronary Drug Eluting Balloons Average Price (2021-2032) & (US$/Unit)
Figure 6. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Region (2021-2032)
Figure 7. World PTCA Coronary Drug Eluting Balloons Production Market Share by Region (2021-2032)
Figure 8. North America PTCA Coronary Drug Eluting Balloons Production (2021-2032) & (K Units)
Figure 9. Europe PTCA Coronary Drug Eluting Balloons Production (2021-2032) & (K Units)
Figure 10. China PTCA Coronary Drug Eluting Balloons Production (2021-2032) & (K Units)
Figure 11. PTCA Coronary Drug Eluting Balloons Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 14. World PTCA Coronary Drug Eluting Balloons Consumption Market Share by Region (2021-2032)
Figure 15. United States PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 16. China PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 17. Europe PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 18. Japan PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 19. South Korea PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 20. ASEAN PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 21. India PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 22. Producer Shipments of PTCA Coronary Drug Eluting Balloons by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for PTCA Coronary Drug Eluting Balloons Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for PTCA Coronary Drug Eluting Balloons Markets in 2025
Figure 25. United States VS China: PTCA Coronary Drug Eluting Balloons Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: PTCA Coronary Drug Eluting Balloons Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: PTCA Coronary Drug Eluting Balloons Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share 2025
Figure 29. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share 2025
Figure 30. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share 2025
Figure 31. World PTCA Coronary Drug Eluting Balloons Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Type in 2025
Figure 33. Paclitaxel-based
Figure 34. limus
Figure 35. Other
Figure 36. World PTCA Coronary Drug Eluting Balloons Production Market Share by Type (2021-2032)
Figure 37. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Type (2021-2032)
Figure 38. World PTCA Coronary Drug Eluting Balloons Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Figure 40. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Use Scenario in 2025
Figure 41. In-Stent Restenosi
Figure 42. De novo
Figure 43. Small Vessel
Figure 44. World PTCA Coronary Drug Eluting Balloons Production Market Share by Use Scenario (2021-2032)
Figure 45. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Use Scenario (2021-2032)
Figure 46. World PTCA Coronary Drug Eluting Balloons Average Price by Use Scenario (2021-2032) & (US$/Unit)
Figure 47. World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Figure 48. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Balloon Platform Mechanics in 2025
Figure 49. Semi-/Compliant
Figure 50. Non-compliant
Figure 51. Other
Figure 52. World PTCA Coronary Drug Eluting Balloons Production Market Share by Balloon Platform Mechanics (2021-2032)
Figure 53. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Balloon Platform Mechanics (2021-2032)
Figure 54. World PTCA Coronary Drug Eluting Balloons Average Price by Balloon Platform Mechanics (2021-2032) & (US$/Unit)
Figure 55. World PTCA Coronary Drug Eluting Balloons Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Application in 2025
Figure 57. Cardiac Catheterization Lab
Figure 58. Hospital
Figure 59. Other
Figure 60. World PTCA Coronary Drug Eluting Balloons Production Market Share by Application (2021-2032)
Figure 61. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Application (2021-2032)
Figure 62. World PTCA Coronary Drug Eluting Balloons Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. PTCA Coronary Drug Eluting Balloons Industry Chain
Figure 64. PTCA Coronary Drug Eluting Balloons Procurement Model
Figure 65. PTCA Coronary Drug Eluting Balloons Sales Model
Figure 66. PTCA Coronary Drug Eluting Balloons Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. PTCA Coronary Drug Eluting Balloons Picture
Figure 2. World PTCA Coronary Drug Eluting Balloons Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World PTCA Coronary Drug Eluting Balloons Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World PTCA Coronary Drug Eluting Balloons Production (2021-2032) & (K Units)
Figure 5. World PTCA Coronary Drug Eluting Balloons Average Price (2021-2032) & (US$/Unit)
Figure 6. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Region (2021-2032)
Figure 7. World PTCA Coronary Drug Eluting Balloons Production Market Share by Region (2021-2032)
Figure 8. North America PTCA Coronary Drug Eluting Balloons Production (2021-2032) & (K Units)
Figure 9. Europe PTCA Coronary Drug Eluting Balloons Production (2021-2032) & (K Units)
Figure 10. China PTCA Coronary Drug Eluting Balloons Production (2021-2032) & (K Units)
Figure 11. PTCA Coronary Drug Eluting Balloons Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 14. World PTCA Coronary Drug Eluting Balloons Consumption Market Share by Region (2021-2032)
Figure 15. United States PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 16. China PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 17. Europe PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 18. Japan PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 19. South Korea PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 20. ASEAN PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 21. India PTCA Coronary Drug Eluting Balloons Consumption (2021-2032) & (K Units)
Figure 22. Producer Shipments of PTCA Coronary Drug Eluting Balloons by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for PTCA Coronary Drug Eluting Balloons Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for PTCA Coronary Drug Eluting Balloons Markets in 2025
Figure 25. United States VS China: PTCA Coronary Drug Eluting Balloons Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: PTCA Coronary Drug Eluting Balloons Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: PTCA Coronary Drug Eluting Balloons Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share 2025
Figure 29. China Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share 2025
Figure 30. Rest of World Based Manufacturers PTCA Coronary Drug Eluting Balloons Production Market Share 2025
Figure 31. World PTCA Coronary Drug Eluting Balloons Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Type in 2025
Figure 33. Paclitaxel-based
Figure 34. limus
Figure 35. Other
Figure 36. World PTCA Coronary Drug Eluting Balloons Production Market Share by Type (2021-2032)
Figure 37. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Type (2021-2032)
Figure 38. World PTCA Coronary Drug Eluting Balloons Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World PTCA Coronary Drug Eluting Balloons Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Figure 40. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Use Scenario in 2025
Figure 41. In-Stent Restenosi
Figure 42. De novo
Figure 43. Small Vessel
Figure 44. World PTCA Coronary Drug Eluting Balloons Production Market Share by Use Scenario (2021-2032)
Figure 45. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Use Scenario (2021-2032)
Figure 46. World PTCA Coronary Drug Eluting Balloons Average Price by Use Scenario (2021-2032) & (US$/Unit)
Figure 47. World PTCA Coronary Drug Eluting Balloons Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Figure 48. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Balloon Platform Mechanics in 2025
Figure 49. Semi-/Compliant
Figure 50. Non-compliant
Figure 51. Other
Figure 52. World PTCA Coronary Drug Eluting Balloons Production Market Share by Balloon Platform Mechanics (2021-2032)
Figure 53. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Balloon Platform Mechanics (2021-2032)
Figure 54. World PTCA Coronary Drug Eluting Balloons Average Price by Balloon Platform Mechanics (2021-2032) & (US$/Unit)
Figure 55. World PTCA Coronary Drug Eluting Balloons Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Application in 2025
Figure 57. Cardiac Catheterization Lab
Figure 58. Hospital
Figure 59. Other
Figure 60. World PTCA Coronary Drug Eluting Balloons Production Market Share by Application (2021-2032)
Figure 61. World PTCA Coronary Drug Eluting Balloons Production Value Market Share by Application (2021-2032)
Figure 62. World PTCA Coronary Drug Eluting Balloons Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. PTCA Coronary Drug Eluting Balloons Industry Chain
Figure 64. PTCA Coronary Drug Eluting Balloons Procurement Model
Figure 65. PTCA Coronary Drug Eluting Balloons Sales Model
Figure 66. PTCA Coronary Drug Eluting Balloons Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
